While we have been forced to come to terms with just how unprepared the world was for a global coronavirus outbreak, since our last comprehensive discussion on the topic, COVID-19 has exploded in the U.S. Updates continue to unfold by the hour and our sector-agnostic, collective need to stay abreast of all latest developments as often and with as much detail as possible remains imperative. Investors persevere in working to determine the increasingly multi-faceted global impacts this outbreak may have as stock concerns have spread and intensified beyond those simply with country-specific exposure.
This call was hosted on April 14, 2020, under the title: “COVID-19 Update: Assessing Latest Dynamics, Treatment Developments & Defining the New Normal.”
You can request a replay & transcript of the Hosted Event discussed above, or any of our Hosted Events, by emailing [email protected].
Coleman Research Group, Inc. (“Coleman” or the “Firm”) sponsors events featuring a wide range of speakers (“Guest Speakers”). The opinions, estimates, projections, and views contained in this summary are those of, and exclusively sourced from, the Guest Speakers and are not reviewed or endorsed by the Guest Speakers. In respect of this summary, Coleman makes no representation or warranty, express or implied, is not providing investment, legal, tax, financial, or accounting advice, and accepts no liability whatsoever. Coleman retains sole discretion as it relates to accessing this information by clients and prospective clients.